Tracking In Vivo Lipolysis of Lipid Nanocarriers Using NIR‐II Polarity‐Sensitive Fluorescent Probes
Small Methods · 2025
DOI: 10.1002/smtd.202402249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2025. Verfasst von Yanlei Zhan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai, 201203, P. R. China. Hauptthemen laut MEDLINE: Lipolysis, Fluorescent Dyes, Nanoparticles, Drug Carriers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Commission of Science and Technology.
Abstract (Originalsprache)
Elucidating in vivo lipolysis is crucial for clarifying the underlying mechanisms and in vivo fates of lipid‐based nanocarriers, which are essential oral drug delivery carriers. Current mainstream methodologies use various in vitro digestion models to predict the in vivo performance of lipid formulations; however, their accuracy is often impeded by the complicated environment of the gastrointestinal tract. Although fluorescence labeling with conventional probes partly reveals the in vivo translocation of lipid nanocarriers, it fails to elucidate the lipolysis process because of poor signal discrimination among nanocarriers, free probes, and mixed micelles (lipolysis end‐products). Here, a polarity‐sensitive probe (PN‐C18) with aggregation‐caused quenching properties for labeling lipid nanocarriers is developed and optimized. PN‐C18 successfully eliminates interference from both free probes and mixed micelles during lipolysis. In a representative in vitro lipolysis model, PN‐C18 labeling shows stronger correlation between fluorescence intensity and lipolysis progression than those of previous methods. In vivo, the translocation and lipolysis of lipid nanoparticles are clearly visualized and effectively monitored, owing to the high tissue‐penetrating capability of PN‐C18 NIR‐II photons. This study provides practical means for elucidating the in vivo fate of lipid‐based drug delivery systems and offers valuable insights and reference for further studies in this domain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai, 201203, P. R. China.
- Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, 200443, P. R. China.
- Fudan Zhangjiang Institute, Shanghai, 201203, P. R. China.
- National Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Shanghai, 201203, P. R. China.
- Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, 201399, P. R. China.
ORCID-Profile: Haisheng He
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Commission of Science and Technology
Zitieren
APA
Zhan, Y., Chang, Z., Liu, C., Zhang, Z., Zhang, R., Lu, Y., Qi, J., Wu, W., & He, H. (2025). Tracking In Vivo Lipolysis of Lipid Nanocarriers Using NIR‐II Polarity‐Sensitive Fluorescent Probes. Small Methods. https://doi.org/10.1002/smtd.202402249
Vancouver
Zhan Y, Chang Z, Liu C, Zhang Z, Zhang R, Lu Y, et al. Tracking In Vivo Lipolysis of Lipid Nanocarriers Using NIR‐II Polarity‐Sensitive Fluorescent Probes. Small Methods. 2025. doi:10.1002/smtd.202402249
BibTeX
@article{Zhan2025,
author = {Zhan, Yanlei and Chang, Zhichao and Liu, Chang and Zhang, Ziyu and Zhang, Runtong and Lu, Yi and Qi, Jianping and Wu, Wei and He, Haisheng},
title = {Tracking In Vivo Lipolysis of Lipid Nanocarriers Using NIR‐II Polarity‐Sensitive Fluorescent Probes},
journal = {Small Methods},
year = {2025},
doi = {10.1002/smtd.202402249}
}
EUVIMED